Unknown

Dataset Information

0

Target arm affinities determine preclinical efficacy and safety of anti-HER2/CD3 bispecific antibody.


ABSTRACT: Systemic cytokine release and on-target/off-tumor toxicity to normal tissues are the main adverse effects limiting the clinical utility of T cell-redirecting therapies. This study was designed to determine how binding affinity for CD3 and tumor target HER2 impact the efficacy and nonclinical safety of anti-HER2/CD3 T cell-dependent antibodies (TDBs). Affinity was found to be a major determinant for the overall tolerability. Higher affinity for CD3 associated with rapidly elevated peripheral cytokine concentrations, weight loss in mice, and poor tolerability in cynomolgus monkeys. A TDB with lower CD3 affinity was better tolerated in cynomolgus monkeys compared with a higher CD3-affinity TDB. In contrast to tolerability, T cell binding affinity had only limited impact on in vitro and in vivo antitumor activity. High affinity for HER2 was critical for the tumor-killing activity of anti-HER2/CD3 TDBs, but higher HER2 affinity also associated with a more severe toxicity profile, including cytokine release and damage to HER2-expressing tissues. The tolerability of the anti-HER2/CD3 was improved by implementing a dose-fractionation strategy. Fine-tuning the affinities for both the tumor target and CD3 is likely a valuable strategy for achieving maximal therapeutic index of CD3 bispecific antibodies.

SUBMITTER: Staflin K 

PROVIDER: S-EPMC7205277 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications


Systemic cytokine release and on-target/off-tumor toxicity to normal tissues are the main adverse effects limiting the clinical utility of T cell-redirecting therapies. This study was designed to determine how binding affinity for CD3 and tumor target HER2 impact the efficacy and nonclinical safety of anti-HER2/CD3 T cell-dependent antibodies (TDBs). Affinity was found to be a major determinant for the overall tolerability. Higher affinity for CD3 associated with rapidly elevated peripheral cyto  ...[more]

Similar Datasets

| S-EPMC5384386 | biostudies-literature
| S-EPMC6694677 | biostudies-literature
| S-EPMC4258008 | biostudies-other
| S-EPMC7829968 | biostudies-literature
| S-EPMC8601150 | biostudies-literature
| S-EPMC3901068 | biostudies-literature
| S-EPMC6188753 | biostudies-literature
2020-11-12 | GSE159547 | GEO
| S-EPMC9388929 | biostudies-literature